drugset / Trial / NCT06699680
Phase 1 Study of PRX019 in Healthy Adult Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
Timeline
- Start
- 2024-11-08
- Primary completion
- 2026-01-16
- Completion
- 2026-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRX019 | Unknown | — | — |
Indications
No indication recorded.